Mobile

Pilot study on safety of four weekly administrations of 7 mg/kg of liposomal amphotericin B (AmBisome®) in antifungal primary prophylaxis treatment of elderly patients with acute lymphoblastic leukemi...

Update Il y a 4 ans
Reference: EUCTR2005-004495-21

Pilot study on safety of four weekly administrations of 7 mg/kg of liposomal amphotericin B (AmBisome®) in antifungal primary prophylaxis treatment of elderly patients with acute lymphoblastic leukemia undergoing induction chemotherapy within the GMALL-Elderly protocol

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To characterize the safety profile of a prophylactic antifungal LAMB treatment of 7 mg/kg, administered as a weekly intravenous infusions over two hours, during induction treatment of acute lymphoblastic leukemia of elderly patients undergoing chemotherapy with GMALL-Elderly 1/2003 protocol for four weeks.

Inclusion criteria

  • Antifungal prophylaxis

Links